← brief for 2026-09-16 · Slowing decline

Ibrutinib-Associated Kaposi Sarcoma and Reversible Renal Manifestation in Chronic Lymphocytic Leukemia

Paper C Peer reviewed Observational

Key takeaways

This case report describes one person with a blood cancer called chronic lymphocytic leukemia. While taking the cancer drug ibrutinib, they got Kaposi sarcoma, a skin and tissue cancer, along with a kidney problem. The kidney problem got better afterward. This is one patient's story. It shows a possible link to the drug, not proof that the drug caused it.

Who did this work

Tahir Alper Cinli (Sağlık Bilimleri Üniversitesi)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-14
https://doi.org/10.4274/csmedj.galenos.2026.2026-7-4